Daphne Zohar

Learn More
Joseph C. Kvedar is in the Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA, Harvard Medical School, Boston, Massachusetts, USA, and Partners Connected Health, Partners Healthcare, Boston, Massachusetts, USA; Alexander L. Fogel is at Stanford University Graduate School of Business and the Stanford University School of(More)
Eric Elenko, Lindsay Underwood & Daphne Zohar are at PureTech, Boston, Massachusetts, USA. e-mail: DaphneNB@puretechhealth.com ple is the collaboration between Google and Johnson & Johnson’s (News Brunswick, NJ) Ethicon to help develop better robotic surgical tools. Despite the increased interest and investment in this arena, some in the biopharmaceutical(More)
devices require FDA premarket review before being marketed. This occurs by two key review processes: the 510(k) premarket notification process for class II devices and premarket approval (PMA) for class III. The vast majority of regulatory activity at CDRH occurs at the class II level along the 510(k) pathway. The 510(k) system is built upon historical(More)
Data explosion. With the rise of ‘big data’, the cost of gathering data in digital form has dropped dramatically. Spotify and Pandora can track and process every segment of every song you listen to and use that information to make decisions about what other content to serve you. This sea change holds true in medicine as well. The National Human Genome(More)
To the Editor: We the undersigned, founders and leaders of biotech companies, write to express our deep concern and opposition to the executive order signed by President Donald Trump on January 27, 2017, barring the entry of citizens from seven countries into the United States1. The United States is the world’s greatest developer of medicines and new(More)
S OF PAPERS PRESENTED AT u ~ T H E 14TH C O N G R E S S OF ~"~" T H E I S R A E L I P H Y T O P A T H O L O G I C A L S O C I E T Y '~Oi~7.OPATlqOk.O February 15-16, 1993 ARO, The Volcani Center, Bet Dagan, Israel A: MONITORING DISEASES AND IDENTIFICATION OF PATHOGENS Extended Summary The Plant Clinic as a Tool for Monitoring Plant Diseases I.S. Ben-Ze 'ev,(More)
In the version of this article initially published, the leadership of the team developing ADCs was incorrectly attributed, for which Nature Biotechnology takes full responsibility. To correct this, on p.265, paragraph 3, “Shen’s team at Genentech” now reads “Jagath R. Junutula (then at Genentech, now at Cellerant Therapeutics in San Carlos, CA, USA) and(More)
S OF PAPERS PRESENTED AT THE 8TH CONFERENCE OF THE E N T O M O L O G I C A L S O C I E T Y OF I S R A E L Basic and Applied Research on Fruit Flies (Diptera: Tephritidae) of Agricultural Importance in Israel
VOLUME 34 NUMBER 3 MARCH 2016 NATURE BIOTECHNOLOGY T past 20 years have witnessed tremendous progress in biotech. Since this journal was re-launched, biotech has continued to be an engine for R&D innovation (Boxes 1 and 2, Figs. 1–4 and Supplementary Table 1), and the public markets for life science companies have matured (Box 3, Fig. 5 and Supplementary(More)